SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JOHN W. who wrote (2608)11/3/1997 8:26:00 PM
From: tommysdad  Read Replies (2) of 6136
 
RE: "introduce 2 new drugs a year (as stated on AGPH's home page)":

This sounds very much like you are suggesting AGPH is promising two new marketed drugs per year.

Actually, what AGPH sets as a goal is putting 2 new drugs per year "into development" < Quoting: "By applying its drug design technologies, Agouron has positioned itself to bring at least two new drugs from research into development each year.">

A very lofty goal. But it will not translate into 2 new approved drugs every year -- what they are talking about is more like 2 compounds will be put into pre-clinical development every year. We're not even talking IND's here. Let's give AGPH the benefit of the doubt and say half of these "2 per year" make it to IND stage (that's very generous). Now we have one IND/year -- an achievable goal potentially. Historically, 75-85% of compounds put into the clinic fail before NDA. That translates to a new drug every third year or so. Still, very respectable for this size of a company, but you do yourself and this thread a disservice by suggesting that the company is promising two new marketed drugs every year. They are not.

But if they do market a new drug every other year or so, you and other AGPH shareholders will be very rich.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News